Evidence map›Paper›PMID 31389641›Full record

ArticleHuman brain mapping2019

Interregional causal influences of brain metabolic activity reveal the spread of aging effects during normal aging.

Xin Di, Marie Wölfer, Mario Amend, Hans Wehrl, Tudor M Ionescu, Bernd J Pichler, Bharat B Biswal, Alzheimer's Disease Neuroimaging Initiative

Open access · hybridAbstract read
In one paragraph

Article in Human brain mapping, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 3 countries.

Xin DiDepartment of Biomedical Engineering, New Jersey Institute of Technology, Newark, New Jersey.ORCID 0000-0002-2422-9016
Marie WölferDepartment of Biomedical Engineering, New Jersey Institute of Technology, Newark, New Jersey.
Mario AmendWerner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tuebingen, Tuebingen, Germany.
Hans WehrlWerner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tuebingen, Tuebingen, Germany.
Tudor M IonescuWerner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tuebingen, Tuebingen, Germany.
Bernd J PichlerWerner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tuebingen, Tuebingen, Germany.
Bharat B BiswalDepartment of Biomedical Engineering, New Jersey Institute of Technology, Newark, New Jersey.ORCID 0000-0002-3710-3500
Alzheimer's Disease Neuroimaging Initiative
Siemens (Germany) · DENew Jersey Institute of Technology · US

Funding

Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
CRCNS: Deciphering the laminar-specific functional connectivity and its vascular and neural correlatesR01AT009829 · NCCIH · NEW JERSEY INSTITUTE OF TECHNOLOGY · PI BISWAL, BHARAT BHUSAN · 2017 to 2019
$400k
CRCNS: Neurophysiological Basis of Brain ConnectivityR01DA038895 · NIDA · NEW JERSEY INSTITUTE OF TECHNOLOGY · PI BISWAL, BHARAT BHUSAN · 2014 to 2016
$381k
AbbVieAlzheimer's AssociationAlzheimer's Disease Neuroimaging InitiativeAlzheimer's Drug Discovery FoundationAraclon BiotechBioClinica, Inc.BiogenBristol-Myers Squibb CompanyCereSpir, Inc.CIHRCogstateDepartment of Defense W81XWH-12-2-0012Eisai Inc.Elan Pharmaceuticals, Inc.Eli Lilly and CompanyEuroImmunF. Hoffmann-La Roche LtdFoundation for the National Institutes of HealthFujirebio USGE HealthcareGenentech, Inc.IXICO Ltd.Janssen Alzheimer Immunotherapy Research & Development, LLC.Johnson & Johnson Pharmaceutical Research & Development, LLC.LumosityLundbeckMerck & Co., Inc.Meso Scale Diagnostics, LLC.NCCIH NIH HHS R01 AT009829NeuroRx ResearchNeurotrack TechnologiesNIA NIH HHS U01 AG024904NIBIB NIH HHSNIDA NIH HHS R01 DA038895NIH HHS R01AT009829NIH HHS R01DA038895NIH HHS U01 AG024904Northern California Institute for Research and EducationNovartis Pharmaceuticals CorporationPfizer Inc.Piramal ImagingServierTakeda Pharmaceutical CompanyTransition Therapeutics
6 · The paper itself

Abstract

During healthy brain aging, different brain regions show anatomical or functional declines at different rates, and some regions may show compensatory increases in functional activity. However, few studies have explored interregional influences of brain activity during the aging process. We proposed a causality analysis framework combining high dimensionality independent component analysis (ICA), Granger causality, and least absolute shrinkage and selection operator regression on longitudinal brain metabolic activity data measured by Fludeoxyglucose positron emission tomography (FDG-PET). We analyzed FDG-PET images from healthy old subjects, who were scanned for at least five sessions with an averaged intersession interval of 1 year. The longitudinal data were concatenated across subjects to form a time series, and the first-order autoregressive model was used to measure interregional causality among the independent sources of metabolic activity identified using ICA. Several independent sources with reduced metabolic activity in aging, including the anterior temporal lobe and orbital frontal cortex, demonstrated causal influences over many widespread brain regions. On the other hand, the influenced regions were more distributed, and had smaller age-related declines or even relatively increased metabolic activity. The current data demonstrated interregional spreads of aging on metabolic activity at the scale of a year, and have identified key brain regions in the aging process that have strong influences over other regions.

Indexed as

AgedAged, 80 and overAgingAlgorithmsBrain ChemistryCausalityFemaleFluorodeoxyglucose F18Frontal LobeHealthy VolunteersHumansImage Processing, Computer-AssistedLongitudinal StudiesMaleMiddle AgedNeuropsychological TestsFluorodeoxyglucose F18Radiopharmaceuticalsaginganterior temporal lobeGranger causalityLASSO regressionmetabolic connectivityorbitofrontal cortex

Identifiers

PMID31389641
PMCPMC6865473
OpenAlexW2965853226

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.